PROMETIC ANNOUNCES FDA ACCEPTANCE OF ITS BIOLOGICS LICENSE APPLICATION FOR PLASMINOGEN (RYPLAZIM™)

October 13, 2017
Posted by: DQ
Posted In: Press Releases 2017
X